Treatment of COVID-19 With Opaganib in Patients With Pneumonia Requiring Oxygen

Summary

Patients diagnosed with COVID-19 infection will be offered treatment with Opaganib, 500 mg Q12 hours. Opaganib will be continuously administered for up to 2 weeks, until discharged on room air (if earlier than 2 weeks).

Timeline

Start

2020-08

Primary completion

2021-02

Completion

2021-06

Drugs

Indications